Tuesday 4 December 2018

Teriflunomide tablets to be marketed by Zydus Cadila in India

Zydus Cadila of India has received final approval to market Teriflunomide tablets from United States of Food and Drug Association (USFDA).

India pricing of Teriflunomide tablets is still not known. Though the market is now available with generic tablets for MS relapsing such as Teru MS 14mg and 7mg. We need to wait and see the tablet form Zydus Cadila for pricing.

Teriflunomide tablets is used to treat relapsing forms of multiple sclerosis (MS). However the tablets is not a cure for MS, it will work in decreasing certain immune system cells which could attack the nerve in brain and spinal cord. It will help in decreasing the number of relapses and help to slow down physical problems caused by multiple sclerosis.

No comments:

Post a Comment